These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26823753)

  • 1. MiR-155 modulates the progression of neuropathic pain through targeting SGK3.
    Liu S; Zhu B; Sun Y; Xie X
    Int J Clin Exp Pathol; 2015; 8(11):14374-82. PubMed ID: 26823753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of lncRNA DILC attenuates neuropathic pain via the SOCS3/JAK2/STAT3 pathway.
    Liu Y; Feng L; Ren S; Zhang Y; Xue J
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-19a targets suppressor of cytokine signaling 1 to modulate the progression of neuropathic pain.
    Wang C; Jiang Q; Wang M; Li D
    Int J Clin Exp Pathol; 2015; 8(9):10901-7. PubMed ID: 26617805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of GAP-43 by inhibition of caspases-3 in a rat model of neuropathic pain.
    Wu F; Miao X; Chen J; Sun Y; Liu Z; Tao Y; Yu W
    Int J Clin Exp Pathol; 2012; 5(9):948-55. PubMed ID: 23119112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPV1, Targeted by miR-338-3p, Induces Neuropathic Pain by Interacting with NECAB2.
    Ma Y; Deng Q; Li S; Chen M; Jin B; Wang M
    J Mol Neurosci; 2021 Jan; 71(1):55-65. PubMed ID: 32557241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal miR-183 delivery suppresses mechanical allodynia in mononeuropathic rats.
    Lin CR; Chen KH; Yang CH; Huang HW; Sheen-Chen SM
    Eur J Neurosci; 2014 May; 39(10):1682-9. PubMed ID: 24612023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 inhibitor WP1066 as a novel therapeutic agent for bCCI neuropathic pain rats.
    Xue ZJ; Shen L; Wang ZY; Hui SY; Huang YG; Ma C
    Brain Res; 2014 Oct; 1583():79-88. PubMed ID: 25084036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-145 ameliorates neuropathic pain via inhibiting inflammatory responses and mTOR signaling pathway by targeting Akt3 in a rat model.
    Shi J; Jiang K; Li Z
    Neurosci Res; 2018 Sep; 134():10-17. PubMed ID: 29162479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA CCAT1 modulates neuropathic pain progression through sponging miR-155.
    Dou L; Lin H; Wang K; Zhu G; Zou X; Chang E; Zhu Y
    Oncotarget; 2017 Oct; 8(52):89949-89957. PubMed ID: 29163801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol facilitates pain attenuation in a rat model of neuropathic pain through the activation of spinal Sirt1.
    Yin Q; Lu FF; Zhao Y; Cheng MY; Fan Q; Cui J; Liu L; Cheng W; Yan CD
    Reg Anesth Pain Med; 2013; 38(2):93-9. PubMed ID: 23337935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of extracellular signal-regulated protein kinases 5 in the spinal cord contributes to the neuropathic pain behaviors induced by CCI in rats.
    Zhang L; Xiao C; Wang JK; Zhang LC; Zeng YM
    Neurol Res; 2009 Dec; 31(10):1037-43. PubMed ID: 19426589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of miR-150 on neuropathic pain process via targeting AKT3.
    Cai W; Zhang Y; Liu Y; Liu H; Zhang Z; Su Z
    Biochem Biophys Res Commun; 2019 Sep; 517(3):532-537. PubMed ID: 31376943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-203 involves in neuropathic pain development and represses Rap1a expression in nerve growth factor differentiated neuronal PC12 cells.
    Li H; Huang Y; Ma C; Yu X; Zhang Z; Shen L
    Clin J Pain; 2015 Jan; 31(1):36-43. PubMed ID: 24451631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-202 modulates the progression of neuropathic pain through targeting RAP1A.
    Fang B; Wei L; Dong K; Niu X; Sui X; Zhang H
    J Cell Biochem; 2019 Mar; 120(3):2973-2982. PubMed ID: 30520098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of microRNA-155 attenuates neuropathic pain by regulating SOCS1 signalling pathway.
    Tan Y; Yang J; Xiang K; Tan Q; Guo Q
    Neurochem Res; 2015 Mar; 40(3):550-60. PubMed ID: 25488154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-384-5p ameliorates neuropathic pain by targeting SCN3A in a rat model of chronic constriction injury.
    Ye G; Zhang Y; Zhao J; Chen Y; Kong L; Sheng C; Yuan L
    Neurol Res; 2020 Apr; 42(4):299-307. PubMed ID: 32098588
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of XIST/miR-137 axis on neuropathic pain by targeting TNFAIP1 in a rat model.
    Zhao Y; Li S; Xia N; Shi Y; Zhao CM
    J Cell Physiol; 2018 May; 233(5):4307-4316. PubMed ID: 29115665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XIST accelerates neuropathic pain progression through regulation of miR-150 and ZEB1 in CCI rat models.
    Yan XT; Lu JM; Wang Y; Cheng XL; He XH; Zheng WZ; Chen H; Wang YL
    J Cell Physiol; 2018 Aug; 233(8):6098-6106. PubMed ID: 29323698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of miR-206 ameliorates chronic constriction injury-induced neuropathic pain in rats via the MEK/ERK pathway by targeting brain-derived neurotrophic factor.
    Sun W; Zhang L; Li R
    Neurosci Lett; 2017 Apr; 646():68-74. PubMed ID: 28130187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of miR-26a-5p on neuropathic pain development by targeting MAPK6 in in CCI rat models.
    Zhang Y; Su Z; Liu HL; Li L; Wei M; Ge DJ; Zhang ZJ
    Biomed Pharmacother; 2018 Nov; 107():644-649. PubMed ID: 30118880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.